Published in Lab Law Weekly, June 10th, 2005
The Appeals Court has lifted the injunction that prohibited Smith & Nephew from manufacturing or selling bipolar radio frequency products in the United States.
The Court of Appeals has also found that one out of 3 of ArthroCare's patents in this case is invalid. Separately, in recent re-examination proceedings, the United States Patent and Trademark Office (USPTO) rejected claims of the other 2 U.S. patents asserted against Smith & Nephew by ArthroCare.
Smith & Nephew is a medical...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Lab Law Weekly